Triple jeopardy in health

This is not all. Not only are we not conserving the existing stock of medicines, the drug pipeline for new antibiotics is drying up, or has done so already

Premium

Sunita Narain

5 min read Last Updated : Oct 01 2023 | 9:46 PM IST

We now know that antibiotics — medicines that we take in times of grave health dangers — are getting increasingly ineffective in killing the microbes that make us ill. This silent pandemic of antimicrobial resistance (AMR) is caused by overuse and misuse of antibiotics, which has made pathogens mutate and build defence mechanisms against these drugs. Today, AMR is taking lives. Estimates say that the inability of life-saving medicines to work led to some five million deaths in 2019.

This is not all. Not only are we not conserving the existing stock of medicines, the drug pipeline for new antibiotics is

Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

Topics : Medicines Indian healthcare Antimicrobial resistance World Health Organization

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in